Guardant Health
GH
#1003
Rank
$23.86 B
Marketcap
$177.80
Share price
1.75%
Change (1 day)
182.94%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Guardant Health (GH) - Total assets

Total assets on the balance sheet as of June 2026 : $1.91 Billion USD

According to Guardant Health 's latest financial reports the company's total assets are $1.91 Billion USD. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Guardant Health - Total assets on balance sheet (from 2017 to 2026)

Total assets by year

Year Total assets Change
2025-12-31$2.01 B35.54%
2024-12-31$1.48 B-16.84%
2023-12-31$1.78 B10.96%
2022-12-31$1.60 B-26.97%
2021-12-31$2.20 B-2.96%
2020-12-31$2.27 B136.02%
2019-12-31$0.96 B63.86%
2018-12-31$0.58 B71.29%
2017-12-31$0.34 B194.2%
2016-12-31$0.11 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Neogen
NEOG
$3.34 B 74.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Natera
NTRA
$2.65 B 38.97%๐Ÿ‡บ๐Ÿ‡ธ USA